111 related articles for article (PubMed ID: 11992323)
1. Summaries for patients. Postmenopausal estrogen replacement therapy and the risk for blood clots: a review from the U.S. Preventive Services Task Force.
Ann Intern Med; 2002 May; 136(9):I42. PubMed ID: 11992323
[No Abstract] [Full Text] [Related]
2. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
Miller J; Chan BK; Nelson HD
Ann Intern Med; 2002 May; 136(9):680-90. PubMed ID: 11992304
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
U.S. Preventive Services Task Force
Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
[No Abstract] [Full Text] [Related]
4. Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2005 May; 142(10):I59. PubMed ID: 15897529
[No Abstract] [Full Text] [Related]
5. [The risk of venous thromboembolism in women during hormone replacement therapy].
Zeltzer D; Shapira I; Berliner S
Harefuah; 1999 Aug; 137(3-4):124-6. PubMed ID: 10959301
[No Abstract] [Full Text] [Related]
6. Summaries for patients. Menopausal hormone therapy to prevent chronic conditions: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med; 2013 Jan; 158(1):I-34. PubMed ID: 23090751
[No Abstract] [Full Text] [Related]
7. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
U.S. Preventive Services Task Force
Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and venous thromboembolism.
Greer IA; Walker ID
Climacteric; 1999 Sep; 2(3):224-31. PubMed ID: 11910601
[No Abstract] [Full Text] [Related]
9. Summaries for patients. Alcohol, postmenopausal hormone therapy, and breast cancer.
Ann Intern Med; 2002 Nov; 137(10):I43. PubMed ID: 12435234
[No Abstract] [Full Text] [Related]
10. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
U.S. Preventive Services Task Force
Ann Intern Med; 2002 Nov; 137(10):834-9. PubMed ID: 12435221
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
Olié V; Canonico M; Scarabin PY
Curr Opin Hematol; 2010 Sep; 17(5):457-63. PubMed ID: 20601871
[TBL] [Abstract][Full Text] [Related]
12. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Gartlehner G; Patel SV; Feltner C; Weber RP; Long R; Mullican K; Boland E; Lux L; Viswanathan M
JAMA; 2017 Dec; 318(22):2234-2249. PubMed ID: 29234813
[TBL] [Abstract][Full Text] [Related]
13. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
14. [From the Cochrane Library: postmenopausal hormone replacement therapy (HRT) does not protect women against cardiovascular disease but does lead to an increased risk of venous thromboembolism].
Hamerlynck JV; Middeldorp S; Scholten RJ
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):546-8. PubMed ID: 16566418
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
Motolese M
Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
[TBL] [Abstract][Full Text] [Related]
16. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
17. Postmenopausal estrogen for treatment of hot flashes: clinical applications.
Nelson HD
JAMA; 2004 Apr; 291(13):1621-5. PubMed ID: 15069050
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
19. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
[No Abstract] [Full Text] [Related]
20. [What to think of postmenopausal hormone replacement therapy after 2002? ].
Ringa V; Uzan S
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):86-9. PubMed ID: 12718317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
